Benzinga | Oct 26, 2020 10:35AM EDT

Why Aileron's Stock Is Trading Lower Today

Aileron Therapeutics (NASDAQ:ALRN) shares are trading lower on Monday after the company on Saturday announced clinical data from its ongoing Phase 1b trial of ALRN-6924.

Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing a novel class of therapeutics called stapled peptides. The company's lead product candidate, ALRN-6924, targets the tumor suppressor p53 for the treatment of a wide variety of cancers.

Aileron Therapeutics shares traded down 23.16% to $1.46 on Monday at the time of publication. The stock has a 52-week high of $2.47 and a 52-week low of 25 cents.